JP2023548632A5 - - Google Patents
Info
- Publication number
- JP2023548632A5 JP2023548632A5 JP2023535666A JP2023535666A JP2023548632A5 JP 2023548632 A5 JP2023548632 A5 JP 2023548632A5 JP 2023535666 A JP2023535666 A JP 2023535666A JP 2023535666 A JP2023535666 A JP 2023535666A JP 2023548632 A5 JP2023548632 A5 JP 2023548632A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- dnaj
- tau
- aav
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105472P | 2020-10-26 | 2020-10-26 | |
| US63/105,472 | 2020-10-26 | ||
| PCT/US2021/056539 WO2022093736A1 (en) | 2020-10-26 | 2021-10-26 | Compositions and methods for the treatment of alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548632A JP2023548632A (ja) | 2023-11-17 |
| JP2023548632A5 true JP2023548632A5 (enExample) | 2024-10-30 |
Family
ID=78676670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535666A Pending JP2023548632A (ja) | 2020-10-26 | 2021-10-26 | アルツハイマー病の処置のための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240025954A1 (enExample) |
| EP (1) | EP4232462A1 (enExample) |
| JP (1) | JP2023548632A (enExample) |
| CN (1) | CN117098771A (enExample) |
| AU (1) | AU2021367952A1 (enExample) |
| CA (1) | CA3199433A1 (enExample) |
| TW (1) | TW202233655A (enExample) |
| WO (1) | WO2022093736A1 (enExample) |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8918616D0 (en) | 1989-08-15 | 1989-09-27 | Univ Glasgow | Herpes simplex virus type 1 mutant |
| US5804413A (en) | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
| GB9415319D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
| US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| AU8605598A (en) | 1997-07-31 | 1999-02-22 | University Of Pittsburgh | Targeted hsv vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| ATE318923T1 (de) | 2000-06-01 | 2006-03-15 | Univ North Carolina | Doppelsträngige parvovirus-vektoren |
| WO2002004482A1 (en) | 2000-07-07 | 2002-01-17 | Panacea Pharmaceuticals, Inc. | Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| JP5136766B2 (ja) | 2004-12-15 | 2013-02-06 | ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | キメラベクター |
| WO2010093784A2 (en) | 2009-02-11 | 2010-08-19 | The University Of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| EP2524037B1 (en) | 2010-01-12 | 2018-05-16 | The University Of North Carolina At Chapel Hill | Restrictive inverted terminal repeats for viral vectors |
| US9169492B2 (en) | 2010-02-05 | 2015-10-27 | The University Of North Carolina At Chapel Hill | Compositions and methods for enhanced parvovirus transduction |
| WO2014053879A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| CA2896066C (en) * | 2012-12-21 | 2022-07-12 | Biogen Ma Inc. | Human anti-tau antibodies |
| US12162929B2 (en) | 2018-02-19 | 2024-12-10 | New York University | Alpha-synuclein single domain antibodies |
| GB201902392D0 (en) * | 2019-02-21 | 2019-04-10 | Cambridge Entpr Ltd | Modular binding proteins |
| KR20220167324A (ko) * | 2020-04-10 | 2022-12-20 | 솔라 바이오사이언시즈 엘엘씨 | 단백질 응집 장애의 치료를 위한 조성물 및 방법 |
| WO2021222168A2 (en) * | 2020-04-28 | 2021-11-04 | Sola Biosciences Llc | Compositions and methods for the treatment of tdp-43 proteinopathies |
-
2021
- 2021-10-26 JP JP2023535666A patent/JP2023548632A/ja active Pending
- 2021-10-26 US US18/033,454 patent/US20240025954A1/en active Pending
- 2021-10-26 TW TW110139655A patent/TW202233655A/zh unknown
- 2021-10-26 CA CA3199433A patent/CA3199433A1/en active Pending
- 2021-10-26 CN CN202180087609.5A patent/CN117098771A/zh active Pending
- 2021-10-26 AU AU2021367952A patent/AU2021367952A1/en active Pending
- 2021-10-26 EP EP21810497.4A patent/EP4232462A1/en active Pending
- 2021-10-26 WO PCT/US2021/056539 patent/WO2022093736A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524414A5 (enExample) | ||
| JP2020522269A5 (enExample) | ||
| JP2020072703A5 (enExample) | ||
| US20240060054A9 (en) | Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography | |
| ES2230569T3 (es) | Funciones accesorias para uso en la produccion de viriones aav recombinantes. | |
| ES2839398T3 (es) | Purificación de partículas de virus adenoasociadas recombinantes que comprende una etapa de purificación de afinidad | |
| JP6042825B2 (ja) | 改変された形質導入プロファイルを有するウイルスベクターならびにその製造および使用の方法 | |
| JP2020505936A5 (enExample) | ||
| JP2009526067A5 (enExample) | ||
| JP2019001805A5 (enExample) | ||
| JP2012521750A5 (enExample) | ||
| JP2017536116A5 (enExample) | ||
| PH12020550094A1 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| JP2020533959A5 (enExample) | ||
| JP2018522529A5 (enExample) | ||
| JP2025518706A (ja) | Ａａｖカプシドバリアント及びその使用 | |
| JP7558535B2 (ja) | アルデヒドデヒドロゲナーゼ欠損症の治療のための遺伝子治療 | |
| TW201704253A (zh) | 殼體 | |
| JP2017510298A5 (enExample) | ||
| JP2023506030A5 (enExample) | ||
| JPWO2012057363A1 (ja) | 神経系細胞への遺伝子導入のためのアデノ随伴ウイルスビリオン | |
| JP2022505687A5 (enExample) | ||
| Bello et al. | Isolation and evaluation of novel adeno-associated virus sequences from porcine tissues | |
| TW201629225A (zh) | 第九因子基因療法 | |
| JP2022531809A5 (enExample) |